A novel form of cell therapy may help patients who are critically ill with acute respiratory distress syndrome (ARDS) brought on by severe COVID-19, according to a study.
A study suggested that a new type of cell therapy may improve the prognosis of patients critically unwell with acute respiratory distress syndrome (ARDS) caused by severe COVID-19.